(See also Overview of Dietary Supplements and National Institutes of Health (NIH): Melatonin.)
Claims
Standard dosage is not established and ranges from 0.5 to 5 mg orally taken 1 hour before usual bedtime on the day of travel and 2 to 4 nights after arrival.
Evidence
Adverse Effects
Drug Interactions
(See also table Some Possible Dietary Supplement–Drug Interactions.)
References
1. Melatonin for jet lag. Drug Ther Bull 58(2):21-24, 2020. doi: 10.1136/dtb.2019.000074
2. Buscemi N, Vandermeer B, Pandya R, et alEvid Rep Technol Assess (Summ) (108):1-7, 2004. doi:10.1037/e439412005-001
3. Ferracioli-Oda E, Qawasmi A, Bloch MHPLoS One 8(5):e63773, 2013. doi: 10.1371/journal.pone.0063773
4. Auld F, Maschauer EL, Morrison I, et alSleep Med Rev 34:10-22, 2017. doi: 10.1016/j.smrv.2016.06.005
5. Li T, Jiang S, Han M, et alFront Neuroendocrinol 52:22-28, 2019. doi: 10.1016/j.yfrne.2018.06.004
6. Liira J, Verbeek JH, Costa G, et al. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work. Cochrane Database Syst Rev (8):CD009776, 2014. doi:10.1002/14651858.CD009776.pub2
7. McDonagh MS, Holmes R, Hsu F: Pharmacologic treatments for sleep disorders in children: a systematic review. J Child Neurol 34(5):237-247, 2019. doi: 10.1177/0883073818821030
8. Hansen MV, Halladin NL, Rosenberg J, Gögenur I, Møller AMCochrane Database Syst Rev (4):CD009861, 2015. doi:10.1002/14651858.CD009861.pub2
9. Erland LA, Saxena PKJ Clin Sleep Med 13(2):275-281, 2017. doi:10.5664/jcsm.6462
10. Auger RR, Burgess HJ, Emens JS, Deriy LV, Thomas SM, Sharkey KM. Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 11(10):1199-1236, 2015 doi:10.5664/jcsm.5100
11. Lelak K, Vohra V, Neuman MI, et alMMWR Morb Mortal Wkly Rep 71(22):725-729, 2022. doi:10.15585/mmwr.mm7122a1
More Information
The following English-language resource may be useful. Please note that THE MANUAL is not responsible for the content of this resource.